CBUS
Cibus Charts New Course with Commercially Driven Gene Editing Approach
Cibus, a pioneer in gene editing technology, marked a significant milestone in its evolution during the fourth quarter of 2025. According to its Q4 2025 conference call transcript, the company has transitioned from an experimental phase to a commercially driven entity with a powerful technology engine. With seven rice customers